Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Figure 4 SNHG5 promotes 5-fluorouracil resistance in colorectal cancer in vivo.
A: Tumor growth after treatment with 5-fluorouracil was assessed using the following formula: V = 1/2 × a2 × b, where a is tumor length and b is tumor width; B: Representative images of trimmed tumors; C: Tumor weight was calculated; D: Ki-67 expression was evaluated in tumor tissues by immunohistochemistry (scale bar = 400 μm). aP < 0.05. bP < 0.01. Con: Control; shSNHG5: SNHG5-short hairpin RNA; shNC: Negative control-short hairpin RNA; 5-Fu: 5-fluorouracil.
- Citation: Wang B, Zhou Q, Cheng CE, Gu YJ, Jiang TW, Qiu JM, Wei GN, Feng YD, Ren LH, Shi RH. Long noncoding RNA SNHG5 promotes 5-fluorouracil resistance in colorectal cancer by regulating miR-26b/p-glycoprotein axis. World J Gastrointest Oncol 2025; 17(5): 102417
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102417.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102417